Navigation Links
Caraco Pharmaceutical Laboratories, Ltd. to Market Generic Sinemet(R) Tablets
Date:11/5/2008

DETROIT, Nov. 5 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE: CPD) announced today, that it has launched Carbidopa and Levodopa tablets on behalf of Sun Pharmaceutical Industries Ltd. (Sun Pharma). Sun Pharma recently received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for generic Sinemet(R) tablets.

Carbidopa and Levodopa tablets are used in the treatment of Parkinson's disease and syndrome. These generic versions of Carbidopa and Levodopa 10 mg / 100 mg, 25 mg / 100 mg, and 25 mg / 250 mg tablets are bioequivalent to Sinemet(R) tablets distributed by Bristol-Myers Squibb. According to IMS Data, these strengths of Carbidopa and Levodopa had US. sales of approximately $70 million for the 12-month period ended June 2008.

Daniel H. Movens, Caraco's Chief Executive Officer, said, "We are pleased to add to our product portfolio by launching Carbidopa and Levodopa tablets immediately to the marketplace. We continue to focus on working towards expanding our product offering as quickly and effectively as possible."

Sinemet(R) is a registered trademark of Merck & Co.

Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures, markets and distributes generic and private-label pharmaceuticals to the nation's largest wholesalers, distributors, drugstore chains and managed care providers.

Safe Harbor: This news release contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially
'/>"/>

SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Reaches Agreement with Labor Union
2. Caraco Pharmaceutical Laboratories, Ltd. to Market Generic Depakote(R) Delayed Release Tablets
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Elavil(R)
4. Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008
5. Caraco Pharmaceutical Laboratories, Ltd. to Announce Fourth Quarter and Fiscal Year 2008 Results on May 29, 2008
6. Caraco Pharmaceutical Laboratories Ltd. Wins Summary Judgment on Generic Ultracet(R)
7. Caraco Pharmaceutical Laboratories Ltd. To Market Generic Ethyol(R)
8. Caraco Pharmaceutical Laboratories Ltd. to Market Generic Protonix(R)
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Metaglip(R)
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Childrens Zyrtec(R) Chewable Tablets for Allergy Relief and Childrens Zyrtec(R) Chewable Tablets for Hives Relief
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... May 20, 2013 Idol lash has designed ... darker and fuller eyelashes in a matter of few weeks. ... online purchase with an extra pack offer to help more ... access this offer on the Idol lash official website. , ... increase the eyelash density up to 82% in just a ...
(Date:5/20/2013)... The Semi Truck Accident Victims Center ... service for an innocent victim of a catastrophic semi ... our services are unparalleled. What this means is if ... of a passenger vehicle involved in a semi truck ... Ohio, New Jersey, Indiana, Maryland, Georgia, Nebraska, Kansas, Michigan, ...
(Date:5/20/2013)... May 20, 2013 iGearUnlimited.com asked schools' technology ... case for students. The answers didn't surprise anyone: , 1. ... use and abuse, 2. Not too bulky – need to ... 3. Built-in kick-stand that works in both vertical and horizontal ... a trackable barcodes on each case, 5. Customizable – schools ...
(Date:5/20/2013)... Los Angeles, CA (PRWEB) May 20, 2013 ... 2013) – MessageSolution, an industry leader in enterprise-class ... of MessageSolution Enterprise eDiscovery Platform 7.0, the latest ... to address all facets of the legal discovery ... May 21-22 in Los Angeles CA. , As ...
(Date:5/20/2013)... you tell a joke well? , Do people roll their eyes ... to be funnier as a speaker, teacher, presenter of any kind? ... , Can't think of a snappy comeback when someone hits you ... you, don't worry. Help is here. I believe that ... learn to tell a joke well. I am not kidding. ...
Breaking Medicine News(10 mins):Health News:Idol Lash Eyelash Growth Enhancer Now Offered Extra Pack for Limited Time Only at HealthCareSupplementz.com 2Health News:Semi Truck Accident Victims Center Urges Family Members Of Victims Injured In A Horrific Semi Truck Accident In Any US State To Call Them First For An Unsurpassed Response 2Health News:New Rugged iPad Case for Bretford Charging Cart Saves the Day for School Deployments 2Health News:New Rugged iPad Case for Bretford Charging Cart Saves the Day for School Deployments 3Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 2Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 3Health News:MessageSolution Releases Enterprise eDiscovery Platform 7.0 at LegalTech 2013 West Coast Expo 4Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 2Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 3Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 4
... -- Tech-savvy teens with acne used their medicine more ... survey, a new study from Wake Forest Baptist Medical ... to test whether a weekly Internet-based communication could improve ... , "Dermatologists have a number of effective topical agents ...
... college students don,t gain anywhere near 15 pounds during their ... than adding "the freshman 15," as it is commonly called, ... during the first year of college. And college has ... The typical freshman only gains about a half-pound more than ...
... eating disorders, yet new research out of the University ... college students to notice the warning signs. On Oct. ... promotion and education, will present her research, titled, "University ... Warning Signs and Risk Factors," at the American Public ...
... could help GPs to speed up the diagnosis and ... common forms of cancer, potentially saving thousands of lives ... and ClinRisk Ltd have shown that the algorithm is ... lung cancer at an earlier stage by ,red-flagging, potentially ...
... reporting on the effectiveness of new therapies for ... science presented at the American College of Gastroenterology,s ... findings from an age-based risk assessment and screening ... aged 50-65, who saw a gastroenterologist for routine ...
... Washington, DC -- The first study to assess ... colon through intensive physician training was presented at ... Meeting, where colorectal cancer detection was an important ... the relationship between the location of pre-cancerous growths ...
Cached Medicine News:Health News:The power of the Internet: It helps improve teens' acne 2Health News:The 'freshman 15' is just a myth, nationwide study reveals 2Health News:The 'freshman 15' is just a myth, nationwide study reveals 3Health News:Research examines college students' knowledge about eating disorders 2Health News:Computer-based tool to improve diagnosis and prognosis for cancer patients 2Health News:Computer-based tool to improve diagnosis and prognosis for cancer patients 3Health News:Computer-based tool to improve diagnosis and prognosis for cancer patients 4Health News:New research on improved treatment options and screening strategies for Hepatitis C 2Health News:New research on improved treatment options and screening strategies for Hepatitis C 3Health News:Research highlights training to improve colorectal cancer detection 2Health News:Research highlights training to improve colorectal cancer detection 3Health News:Research highlights training to improve colorectal cancer detection 4
(Date:5/16/2013)... NORTH CHICAGO, Ill. and MECHELEN, ... NV (Euronext: GLPG) and AbbVie (NYSE: ABBV ... development collaboration to include Crohn,s disease.  Galapagos will fund ... which is designed to facilitate rapid progression into Phase ... Q2 2015, AbbVie will pay Galapagos $50 million.  The ...
(Date:5/16/2013)... May 16, 2013  Today, the National Patient Advocate ... House of Representatives recently approved a bill that ... charging patients higher out-of-pocket fees for newer, more expensive ... which have more severe side-effects. However, the bill was ... which will continue to be a barrier to patients ...
(Date:5/16/2013)... THOUSAND OAKS, Calif. , May 16, 2013  Amgen ... Global Life Sciences Conference on Tuesday, May 21, 2013, at ... York City , beginning at 10:00 a.m. Eastern Daylight ... senior vice president of Research and Development at Amgen, will ... be accessed from the Events Calendar on Amgen,s website, ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... Corporation (Nasdaq: KNSY ) announced today that it ... facility with Wells Fargo Bank, National Association. The ... on May 25, 2014, with the option to extend it ... conditions. The credit facility allows the Company to use borrowings ...
... Savient Pharmaceuticals, Inc. (Nasdaq: SVNT ) ... filed by its wholly owned subsidiary, Savient Pharma ... the treatment of chronic gout in adult patients ... the European Medicines Agency (EMA).  The MAA has ...
Cached Medicine Technology:Savient Pharmaceuticals Marketing Authorization Application for KRYSTEXXA® Accepted for Review by European Medicines Agency 2Savient Pharmaceuticals Marketing Authorization Application for KRYSTEXXA® Accepted for Review by European Medicines Agency 3Savient Pharmaceuticals Marketing Authorization Application for KRYSTEXXA® Accepted for Review by European Medicines Agency 4
... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
... a complete line of enteric ... monoclonal and monoclonal/polyclonal antibody-based ELISA ... enteric pathogens in fecal specimens. ... Clostridium difficile, Entamoeba histolytica, Giardia, ...
Inquire...
Medicine Products: